BETHESDA, Md., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Micromet, Inc. (Nasdaq:MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and Chief Executive Officer, Christian Itin, will present at The Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009 in New York City. A simultaneous webcast of the event will be available on the company’s website at www.micromet-inc.com.
